GLP-1 Receptor Agonists vs SGLT2 Inhibitors for Alzheimer’s Disease Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis

Silva LL, Valverde MES, Silva AMP, Braz LDG, da Silva KK, Aguiar EM, Volta VD, de Oliveira C, Alves RR, Andreão FF, Moura CB, Santos DH.

Open source

DOI: 10.64898/2026.07.22.26358702
Published: 2026-07-24
Container: Not recorded
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 39/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.07.22.26358702,
  title = {GLP-1 Receptor Agonists vs SGLT2 Inhibitors for Alzheimer’s Disease Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis},
  author = {Silva LL and  Valverde MES and  Silva AMP and  Braz LDG and  da Silva KK and  Aguiar EM and  Volta VD and  de Oliveira C and  Alves RR and  Andreão FF and  Moura CB and  Santos DH.},
  year = {2026},
  doi = {10.64898/2026.07.22.26358702},
  url = {https://doi.org/10.64898/2026.07.22.26358702}
}

RIS

TY  - JOUR
TI  - GLP-1 Receptor Agonists vs SGLT2 Inhibitors for Alzheimer’s Disease Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis
AU  - Silva LL
AU  -  Valverde MES
AU  -  Silva AMP
AU  -  Braz LDG
AU  -  da Silva KK
AU  -  Aguiar EM
AU  -  Volta VD
AU  -  de Oliveira C
AU  -  Alves RR
AU  -  Andreão FF
AU  -  Moura CB
AU  -  Santos DH.
PY  - 2026
DO  - 10.64898/2026.07.22.26358702
UR  - https://doi.org/10.64898/2026.07.22.26358702
ER  -

APA

LL, S., MES, V., AMP, S., LDG, B., KK, D. S., EM, A., VD, V., C, D. O., RR, A., FF, A., CB, M., & DH., S. (2026). GLP-1 Receptor Agonists vs SGLT2 Inhibitors for Alzheimer’s Disease Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis. https://doi.org/10.64898/2026.07.22.26358702

Source records

europe-pmc · retrieved 2026-09-25T11:27:47.642Z